We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
-4.27%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$24.5B
AUM Growth
-$123M
(-0.5%)
Cap. Flow
+$15.2B
Cap. Flow
% of AUM
62.04%
Top 10 Holdings %
Top 10 Hldgs %
35.31%
Holding
1,687
New
95
Increased
1,038
Reduced
411
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$4.51B |
| 2 |
MakeMyTrip
MMYT
|
+$2.46B |
| 3 |
Trip.com Group
TCOM
|
+$797M |
| 4 |
Yum China
YUMC
|
+$544M |
| 5 |
Alibaba
BABA
|
+$490M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$88.7M |
| 2 |
Pfizer
PFE
|
+$81.1M |
| 3 |
Blackrock
BLK
|
+$71.8M |
| 4 |
US Bancorp
USB
|
+$51.4M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$33.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.26% |
| 2 | Consumer Discretionary | 9.29% |
| 3 | Communication Services | 9.15% |
| 4 | Healthcare | 7.13% |
| 5 | Financials | 5.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
1401
DELISTED
Sage Therapeutics
SAGE
| $17K | ﹤0.01% |
2,057
+18
| +0.9% | +$132 |
|
|
WSR
1402
DELISTED
Whitestone REIT
WSR
| $16.9K | ﹤0.01% |
1,163
-25
| -2% | -$344 |
|
1403
Savara
SVRA
$1.17B
| $16.7K | ﹤0.01% |
5,743
+24
| +0.4% | +$66 |
|
1404
Tyra Biosciences
TYRA
$1.51B
| $16.5K | ﹤0.01% |
1,693
+7
| +0.4% | +$91 |
|
1405
Omeros
OMER
$992M
| $16.4K | ﹤0.01% |
1,939
+8
| +0.4% | +$71 |
|
1406
UroGen Pharma
URGN
$2.39B
| $16.3K | ﹤0.01% |
1,456
+50
| +4% | +$533 |
|
|
AHRT
1407
AH Realty Trust
AHRT
$501M
| $16.1K | ﹤0.01% |
2,153
-71
| -3% | -$645 |
|
1408
SITE Centers
SITC
$156M
| $16.1K | ﹤0.01% |
1,275
-41
| -3% | -$584 |
|
1409
Aaon
AAON
$7.03B
| $15.8K | ﹤0.01% |
203
+4
| +2% | +$413 |
|
1410
Cullinan Oncology
CGEM
$1.26B
| $15.8K | ﹤0.01% |
1,974
+34
| +2% | +$326 |
|
1411
HUTCHMED
HCM
$2.13B
| $15.8K | ﹤0.01% |
1,038
+4
| +0.4% | +$59 |
|
|
INN
1412
Summit Hotel Properties
INN
$655M
| $15.8K | ﹤0.01% |
2,928
-95
| -3% | -$603 |
|
|
ORKA
1413
Oruka Therapeutics
ORKA
$7.11B
| $15.7K | ﹤0.01% |
1,253
+87
| +7% | +$1.08K |
|
1414
Precigen
PGEN
$2.45B
| $15.6K | ﹤0.01% |
9,800
+41
| +0.4% | +$65 |
|
|
ZK
1415
DELISTED
Zeekr
ZK
| $15.5K | ﹤0.01% |
640
+33
| +5% | +$877 |
|
|
VERV
1416
DELISTED
Verve Therapeutics
VERV
| $15.5K | ﹤0.01% |
2,971
+150
| +5% | +$1K |
|
|
DFTX
1417
Definium Therapeutics
DFTX
$5.75B
| $15.2K | ﹤0.01% |
2,454
+10
| +0.4% | +$72 |
|
1418
Theravance Biopharma
TBPH
$878M
| $15.2K | ﹤0.01% |
1,645
+6
| +0.4% | +$56 |
|
1419
Phathom Pharmaceuticals
PHAT
$742M
| $15.1K | ﹤0.01% |
2,288
+9
| +0.4% | +$55 |
|
1420
Relay Therapeutics
RLAY
$4.4B
| $15K | ﹤0.01% |
5,520
-58
| -1% | -$227 |
|
|
XRN
1421
Chiron Real Estate Inc
XRN
$480M
| $15K | ﹤0.01% |
343
-5
| -1% | -$207 |
|
1422
State Street Blackstone Senior Loan ETF
SRLN
$5.37B
| $15K | ﹤0.01% |
364
-30
| -8% | -$1.25K |
|
1423
Keros Therapeutics
KROS
$222M
| $14.7K | ﹤0.01% |
1,360
+10
| +0.7% | +$116 |
|
|
TRML
1424
DELISTED
Tourmaline Bio
TRML
| $14.6K | ﹤0.01% |
879
+25
| +3% | +$401 |
|
1425
Phibro Animal Health
PAHC
$1.37B
| $14.6K | ﹤0.01% |
681
+3
| +0.4% | +$67 |
|
Similar funds
Mirae Asset Global Investments's Q1 2025 Portfolio in Review
As of Q1 2025, Mirae Asset Global Investments held 1,687 positions worth $24.5B, down 0.5% from $24.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Mirae Asset Global Investments deployed $15.2B of net new capital in Q1 2025, opening 95 new positions and adding to 1,038 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $16.3M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $88.7M trimmed.
- Mirae Asset Global Investments's largest Q1 2025 buy was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $16.3M.
- Mirae Asset Global Investments added most to Pinduoduo in Q1 2025, an estimated $4.51B increase.
- Mirae Asset Global Investments's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $88.7M.
- Mirae Asset Global Investments fully exited State Street Utilities Select Sector SPDR ETF in Q1 2025, selling an estimated $8.71M.
- Mirae Asset Global Investments's ten largest holdings make up 35% of its $24.5B portfolio in Q1 2025.
- Mirae Asset Global Investments opened 95 new positions and closed 99 in Q1 2025.
- Mirae Asset Global Investments's portfolio value fell 0.5% quarter-over-quarter to $24.5B.
Based on Mirae Asset Global Investments's 13F filing for Q1 2025, filed 24 Apr 2025.